Prevalence and Specificity of Red Blood Cell Alloimmunization Among Transfusion Recipients in a Portuguese Hospital
- 1Department of Hematology and Transfusion Medicine, Local Health Unit of Trás-os-Montes e Alto Douro, Vila Real, Portugal
- 2Department of Veterinary Sciences, University of Trás-os-Montes e Alto Douro (UTAD), Vila Real, Portugal
- 3Animal and Veterinary Research Center (CECAV), Associated Laboratory for Animal and Veterinary Science - AL4AnimalS, University of Trás-os-Montes e Alto Douro (UTAD), Vila Real, Portugal
Abstract
Background/Aim: The transfusion of red blood cells (RBCs) is a vital and widely used support therapy. Although often lifesaving, it carries certain risks, as it exposes the patient to alloimmunization due to exposure to various antigens. Despite its importance, the relative frequency of RBC alloantibodies within the general patient population in Portugal has not been extensively studied. This study aimed to investigate the prevalence of RBC alloimmunization in patients attending a Northern Portuguese Hospital Center.
Patients and Methods: We conducted a 3-year retrospective study to investigate the incidence of RBC alloimmunization in patients who received RBC transfusion at a hospital center in Northern Portugal and characterized the target population according to demographic data; ABO, Rh, and Kell blood groups; associated pathology; hospital department; and number of RBC transfusions.
Results: The alloimmunization rate was 1.3% in the study population of 4,079 patients who received RBC transfusion, with the most common antibody being anti-K (18.5%), followed by anti-Lua (13.0%), and anti-E (11.1%). Among the 54 patients that developed alloimmunization, 75.9% developed only one alloantibody, 9.3% presented two alloantibodies, and only 1.9% of the cases developed three alloantibodies; specificity was not identifiable for the remainder. Hematological malignancies were the most frequently observed pathology in the alloimmunized population (25.9%), with myelodysplastic syndrome being the most common (13.0%).
Conclusion: This study demonstrates the importance of characterizing alloimmunized populations to identify high-risk groups. Based on this understanding, it becomes feasible to implement targeted preventive measures to reduce alloimmunization rates and optimize the use of available resources.
Related
- Prevalence and predictors of early blood transfusion in renal transplant recipients: a retrospective study.
- Secondary (anamnestic) anti D alloimmunization following transfusion of a DEL phenotype rhesus D negative unit: A case report highlighting the need for DEL screening in India.
- Impact of luspatercept in beta-thalassemia major with alloimmunization: A case report
- Type I interferon signature strength correlates with alloimmunization-associated transcriptomic programs in systemic lupus erythematosus: A multi-cohort analysis
- FROM SCIENCE TO CLINICAL PRACTICE: THE EFFECT OF PROPHYLACTIC GENOTYPIC MATCHING ON ALLOIMMUNIZATION, AUTOIMMUNIZATION AND RED CELL SURVIVAL IN PATIENTS WITH SICKLE CELL DISEASE
BibTeX
@article{sousa2026prevalence,
title = {{Prevalence and Specificity of Red Blood Cell Alloimmunization Among Transfusion Recipients in a Portuguese Hospital}},
author = {ANA LUÍSA MOTA SOUSA and ANA CRISTINA SILVESTRE-FERREIRA and FILIPA MARIA FERNANDES DE BARROS SANCHES and FELISBINA LUÍSA QUEIROGA and JOSÉ JOAQUIM COSTA},
journal = {In Vivo},
year = {2026},
month = oct,
doi = {10.21873/invivo.14505},
url = {https://doi.org/10.21873/invivo.14505},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Prevalence and Specificity of Red Blood Cell Alloimmunization Among Transfusion Recipients in a Portuguese Hospital
AU - ANA LUÍSA MOTA SOUSA
AU - ANA CRISTINA SILVESTRE-FERREIRA
AU - FILIPA MARIA FERNANDES DE BARROS SANCHES
AU - FELISBINA LUÍSA QUEIROGA
AU - JOSÉ JOAQUIM COSTA
PY - 2026
DA - 2026/10/29
JO - In Vivo
DO - 10.21873/invivo.14505
UR - https://doi.org/10.21873/invivo.14505
AB - Background/Aim: The transfusion of red blood cells (RBCs) is a vital and widely used support therapy. Although often lifesaving, it carries certain risks, as it exposes the patient to alloimmunization due to exposure to various antigens. Despite its importance, the relative frequency of RBC alloantibodies within the general patient population in Portugal has not been extensively studied. This study aimed to investigate the prevalence of RBC alloimmunization in patients attending a Northern Portuguese Hospital Center. Patients and Methods: We conducted a 3-year retrospective study to investigate the incidence of RBC alloimmunization in patients who received RBC transfusion at a hospital center in Northern Portugal and characterized the target population according to demographic data; ABO, Rh, and Kell blood groups; associated pathology; hospital department; and number of RBC transfusions. Results: The alloimmunization rate was 1.3% in the study population of 4,079 patients who received RBC transfusion, with the most common antibody being anti-K (18.5%), followed by anti-Lua (13.0%), and anti-E (11.1%). Among the 54 patients that developed alloimmunization, 75.9% developed only one alloantibody, 9.3% presented two alloantibodies, and only 1.9% of the cases developed three alloantibodies; specificity was not identifiable for the remainder. Hematological malignancies were the most frequently observed pathology in the alloimmunized population (25.9%), with myelodysplastic syndrome being the most common (13.0%). Conclusion: This study demonstrates the importance of characterizing alloimmunized populations to identify high-risk groups. Based on this understanding, it becomes feasible to implement targeted preventive measures to reduce alloimmunization rates and optimize the use of available resources.
SN - 0258-851X
SN - 1791-7549
ER -